88 Energy Ltd

88 Energy continues to look forward to an Icewine farm-out

A deal would potentially tee up an ‘exploration/appraisal’ well next year

oil and gas operations
A farm-out is expected to be agreed in this quarter

88 Energy Ltd (LON:88E) continues to look forward to a potential farm-out deal for its Project Icewine conventional project area in Alaska.

In a quarterly update, the explorer said it expects that the deal is targeted in the second quarter.

“The farm-out process has now progressed to the next stage, with a preferred bidder selected and discussions underway,” the company said.

WATCH: 88 Energy's chief talks Icewine farm-out

It would potentially tee up an ‘exploration/appraisal’ well next year, the company told investors.

In the meantime, the company also intends to advance its shale portfolio. It noted that evaluation work continued in the past quarter, following the two prior HRZ shale wells, and, it is planning to launch a separate farm-out process during the current year.

88 Energy also provided a debrief of the Winx exploration well which failed to find commercial hydrocarbons, though it was completed on time, without incident, and slightly under budget.

It noted that the processing of 3D seismic data for the Yukon project area is now complete, and currently a resource estimation process is underway.

Quick facts: 88 Energy Ltd

Price: £0.01

Market: AIM
Market Cap: £56.98 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...



Full interview: Scancell back in the clinic with a phase II trial of its...

Scancell Holdings PLC's (LON:SCLP) Cliff Holloway tells Proactive London's Andrew Scott they've begun the UK arm of the phase II trial of its flagship skin cancer treatment. The trial is testing the safety and efficacy of SCIB1 in metastatic melanoma patients who are also receiving Merck’s...

7 hours, 42 minutes ago

2 min read